Stifel Financial Corp Edesa Biotech, Inc. Transaction History

Stifel Financial Corp

  • $86.8 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$4.2 - $11.92 $98,439 - $279,380
-23,438 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$4.25 - $8.14 $33,205 - $63,597
7,813 Added 50.0%
23,438 $100,000
Q3 2020

Nov 16, 2020
BUY
$4.65 - $9.45 $72,656 - $147,656
15,625 New
15,625 $126,000

About Edesa Biotech, Inc.

EDSA Quotes by TradingView
  • Ticker EDSA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,462,300
  • Market Cap $66.3M
  • Description
  • Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...
More about EDSA
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email